Chemical Synapses - Biophysical Studies
化学突触 - 生物物理研究
基本信息
- 批准号:7169596
- 负责人:
- 金额:$ 33.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1977
- 资助国家:美国
- 起止时间:1977-12-01 至 2009-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAlzheimer&aposs DiseaseAminesAmino AcidsAmmoniumAttention Deficit DisorderBindingBinding SitesC-terminalCationsChargeChemical SynapseCholinergic ReceptorsCollaborationsCoupledCrohn&aposs diseaseDataDoseEmbryoEnergy TransferEstersEventFluoresceinFluoresceinsFluorescenceFluorescence Resonance Energy TransferFrontal Lobe EpilepsyHealthHelix (Snails)Ion ChannelKineticsLanthanoid Series ElementsMeasurementMeasuresMolecular ConformationMotionMuscleMutationN-terminalNeuronsNicotinic ReceptorsObject AttachmentPainParkinson DiseasePeptidesPharmacotherapyPreparationProlineRecording of previous eventsRestRhodamineRhodaminesRoentgen RaysRotationSchizophreniaSerotoninSerotonin Receptors 5-HT-3SideSiteSpeedStructureSudden infant death syndromeSystemTailTestingTryptophanVertebral columnXenopus oocyteamino groupbaseear helixinsightknowledge of resultsnicotinic receptor alpha4beta2receptorreceptor functionresearch studyresponsesmoking cessation
项目摘要
DESCRIPTION (provided by applicant): This project studies the structure and function of molecules in the Cys-loop receptor superfamily: the muscle nicotinic acetylcholine receptor (nAChR), the neuronal alpha4beta2 nAChR, and the serotonin 5-HT3 receptor. Hypothesis 1 states that three events occur in the following sequence at the agonist binding site, (a) The charged amine / ammonium group of the agonist is attracted to the site by a monopole-monopole interaction with fixed negative .charges on side chains, (b) For agonists with an amino group (not a quaternary ammonium group), this interaction is stabilized by an H-bond to the backbone carbonyl of the 149-150 peptide bond, (c) The earliest conformational change places the agonist in a cation-pi interaction at tryptophan alpha149. Hypothesis 2 states that ye M2-M3 linker undergoes a change in backbone conformation during gating. Hypothesis 3 states that during channel activation, the upper M2 helix of all five subunits re-orients with respect to neighboring helices. Hypothesis 4 states that the dynamic, history- dependent functional interaction between alpha4beta2 and P2X2 receptors occurs via the beta2-M3-M4 loop and the P2X2 C-terminal tail. Hypotheses 1 and 2 will be tested with macroscopic and single-channel electrophysiological assessments of receptors bearing unnatural amino-acid side chains and unnatural backbone linkages. Hypotheses 1, 3, and 4 will be tested in measurements based on direct fluorescence of tethered probes, fluorescence resonance energy transfer (FRET), and lanthanide-based resonance energy transfer (LRET). The resulting knowledge about acetylcholine receptors and 5-HT3 receptors may provide both pathophysiological insights and better drug therapies for health challenges including smoking cessation, Parkinson's disease, Alzheimer's disease, pain, Crohn's disease, sudden infant death syndrome, attention deficit disorder, autosomal dominant nocturnal frontal lobe epilepsy, and schizophrenia.
描述(由申请人提供):本项目研究半胱氨酸环受体超家族中分子的结构和功能:肌肉烟碱乙酰胆碱受体(nAChR)、神经元α 4 β 2 nAChR和5-羟色胺5-HT 3受体。假设1指出,在激动剂结合位点按以下顺序发生三个事件:(a)激动剂的带电荷的胺/铵基团通过侧链上带有固定负电荷的胆甾醇-胆甾醇相互作用被吸引到该位点,(B)对于具有氨基的激动剂,(不是季铵基团),这种相互作用通过与149-150肽键的骨架羰基的H-键来稳定,(c)最早的构象变化使激动剂在色氨酸α 149处发生阳离子-π相互作用。假设2指出,M2-M3接头在门控期间经历骨架构象的变化。假设3指出,在通道激活期间,所有五个亚基的上部M2螺旋相对于相邻螺旋重新定向。假设4指出,α 4 β 2和P2 X2受体之间的动态的、历史依赖性的功能相互作用通过β 2-M3-M4环和P2 X2 C-末端尾发生。假设1和2将通过对带有非天然氨基酸侧链和非天然骨架连接的受体进行肉眼和单通道电生理学评估进行检验。假设1、3和4将在基于束缚探针的直接荧光、荧光共振能量转移(FRET)和基于镧系元素的共振能量转移(LRET)的测量中进行测试。关于乙酰胆碱受体和5-HT 3受体的知识可以为健康挑战提供病理生理学见解和更好的药物治疗,包括戒烟,帕金森病,阿尔茨海默病,疼痛,克罗恩病,婴儿猝死综合征,注意力缺陷障碍,常染色体显性夜间额叶癫痫和精神分裂症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Henry A. Lester其他文献
Antagonists Pharmacologically Chaperone Opioid Receptors
- DOI:
10.1016/j.bpj.2019.11.328 - 发表时间:
2020-02-07 - 期刊:
- 影响因子:
- 作者:
Stephen Grant;Anand K. Muthusamy;Andres Collazo;Henry A. Lester - 通讯作者:
Henry A. Lester
Quantification Of Sensitized FRET From Fluorescent GAT1 γ-aminobutyric Acid Transporters Distinguishes Between Subsurface And Plasma Membrane Resident Oligomers And Predicts Function
- DOI:
10.1016/j.bpj.2008.12.1341 - 发表时间:
2009-02-01 - 期刊:
- 影响因子:
- 作者:
Fraser J. Moss;Princess I. Imoukheude;Jia Hu;Joanna L. Jankowsky;Michael W. Quick;Henry A. Lester - 通讯作者:
Henry A. Lester
Effects of Chronic Menthol at Alpha3Beta4 (α3β4)-Containing Nicotinic Acetylcholine Receptors
- DOI:
10.1016/j.bpj.2017.11.1691 - 发表时间:
2018-02-02 - 期刊:
- 影响因子:
- 作者:
Selvan Bavan;Suparna Patowary;Charlene H. Kim;Brandon J. Henderson;Henry A. Lester - 通讯作者:
Henry A. Lester
Cellular Basis Of Nicotine-induced nAChr Upregulation
- DOI:
10.1016/j.bpj.2008.12.763 - 发表时间:
2009-02-01 - 期刊:
- 影响因子:
- 作者:
Rahul Srinivasan;Rigo Pantoja;Sindhuja Kadambi;Henry A. Lester - 通讯作者:
Henry A. Lester
Microscopy Using Fluorescent Drug Biosensors for “Inside-Out Pharmacology”
- DOI:
10.1016/j.bpj.2017.11.1990 - 发表时间:
2018-02-02 - 期刊:
- 影响因子:
- 作者:
Anand K. Muthusamy;Amol V. Shivange;Aaron L. Nichols;Aron Kamajaya;Janice Jeon;Philip M. Borden;Jonathan S. Marvin;Elizabeth K. Unger;Huan Bao;Edwin R. Chapman;Lin Tian;Loren L. Looger;Henry A. Lester - 通讯作者:
Henry A. Lester
Henry A. Lester的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Henry A. Lester', 18)}}的其他基金
Fluorescent biosensors for subcellular pharmacokinetics
用于亚细胞药代动力学的荧光生物传感器
- 批准号:
9353864 - 财政年份:2016
- 资助金额:
$ 33.41万 - 项目类别:
Fluorescent biosensors for subcellular pharmacokinetics
用于亚细胞药代动力学的荧光生物传感器
- 批准号:
9163507 - 财政年份:2016
- 资助金额:
$ 33.41万 - 项目类别:
Fluorescent biosensors for subcellular pharmacokinetics
用于亚细胞药代动力学的荧光生物传感器
- 批准号:
10004118 - 财政年份:2016
- 资助金额:
$ 33.41万 - 项目类别:
Fluorescent biosensors for subcellular pharmacokinetics
用于亚细胞药代动力学的荧光生物传感器
- 批准号:
9764387 - 财政年份:2016
- 资助金额:
$ 33.41万 - 项目类别:
Beta2 nicotine receptor subunits: biomarkers for dependence
Beta2 尼古丁受体亚基:依赖的生物标志物
- 批准号:
8913108 - 财政年份:2014
- 资助金额:
$ 33.41万 - 项目类别:
Beta2 nicotine receptor subunits: biomarkers for dependence
Beta2 尼古丁受体亚基:依赖的生物标志物
- 批准号:
9328036 - 财政年份:2014
- 资助金额:
$ 33.41万 - 项目类别:
Beta2 nicotine receptor subunits: biomarkers for dependence
Beta2 尼古丁受体亚基:依赖的生物标志物
- 批准号:
9316151 - 财政年份:2014
- 资助金额:
$ 33.41万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




